Medtronic

YTD

ALL

Trade Medtronic 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MDT

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit.

CEO

Geoffrey Straub Martha

CEOGeoffrey Straub Martha

Employees

95,000

Employees95,000

Headquarters

Galway, Galway

HeadquartersGalway, Galway

Founded

2014

Founded2014

Employees

95,000

Employees95,000

MDT Key Statistics

Market cap

110.77B

Market cap110.77B

Price-Earnings ratio

24.18

Price-Earnings ratio24.18

Dividend yield

3.28%

Dividend yield3.28%

Average volume

7.67M

Average volume7.67M

High today

$86.30

High today$86.30

Low today

$86.28

Low today$86.28

Open price

$86.48

Open price$86.48

Volume

3.27K

Volume3.27K

52 Week high

$106.33

52 Week high$106.33

52 Week low

$79.55

52 Week low$79.55

Stock Snapshot

The current Medtronic(MDT) stock price is $86.28, with a market capitalization of 110.77B. The stock trades at a price-to-earnings (P/E) ratio of 24.18 and offers a dividend yield of 3.3%.

As of 2026-04-07, Medtronic(MDT) stock has fluctuated between $86.28 and $86.30. The current price stands at $86.28, placing the stock 0.0% above today's low and -0.0% off the high.

The Medtronic(MDT)'s current trading volume is 3.27K, compared to an average daily volume of 7.67M.

In the last year, Medtronic(MDT) shares hit a 52-week high of $106.33 and a 52-week low of $79.55.

MDT News

TipRanks 2h

Medtronic price target lowered to $110 from $117 at Citi

Citi analyst Joanne Wuensch lowered the firm’s price target on Medtronic (MDT) to $110 from $117 and keeps a Buy rating on the shares. The firm adjusted targets...

Simply Wall St 11h

If You Believe In AI Healthcare Then These Three Stocks Could Shape Your Next Cycle

AI is starting to reshape how healthcare is delivered, from spotting disease earlier to tailoring treatments and cutting wasted time in hospitals, just as energ...

TipRanks 21h

Medtronic: MiniMed IPO Dilution and Diabetes Spin-Off Limit Near-Term Upside, Justifying Hold Rating

Medtronic, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Rick Wise from Stifel Nicolaus maintained a Hold rating on the s...

Analyst ratings

67%

of 33 ratings

Buy

66.7%

Hold

33.3%

Sell

More MDT News

Simply Wall St 2d

Should Medtronic’s New AI Surgical and Cardiac Approvals Prompt a Fresh Look from Investors?

In late March 2026, Medtronic reported a series of U.S. FDA clearances and approvals across cardiac and surgical devices, including the AI-enabled Stealth AXiS...

Simply Wall St 5d

Medtronic Valuation Check As New FDA And AI Milestones Draw Fresh Attention

Medtronic (MDT) is back in focus after fresh U.S. Food and Drug Administration clearance for its AI-enabled Stealth AXiS surgical system in cranial and ENT proc...

Nasdaq 6d

MDT Stock May Gain From FDA's Nod for Stealth AXiS Surgical System

Medtronic plc MDT recently announced that it has secured the FDA’s approval for the Stealth AXiS surgical system for cranial and ear, nose and throat (ENT) proc...

People also own

Based on the portfolios of people who own MDT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.